Abilify 15 mg 10 tablets

ABILIFY 15 mg 10 tablets

Composition:

Each tablet contains:
Active ingredient: aripiprazole — 15 mg

 Description:

Antipsychotic medication with partial agonist activity at dopamine and serotonin receptors. Offers a balanced efficacy and tolerability profile for various psychiatric conditions.

Indications for Use:

Schizophrenia (adults and adolescents 13–17 years)
Acute manic and mixed episodes in Bipolar I Disorder
Adjunctive treatment of Major Depressive Disorder (adults)
Irritability associated with Autistic Disorder (children 6–17 years)
Tourette’s Disorder (children 6–18 years)

Dosage and Administration:

Taken once daily with or without food. Dose depends on indication and age:
Schizophrenia: adults — 10–15 mg/day, adolescents — start at 2 mg, target 10 mg
Bipolar Disorder: adults — 15 mg/day, pediatrics — start at 2 mg, titrate to 10 mg
Depression: start at 2–5 mg/day, up to 15 mg/day
Autism-related irritability: 5–15 mg/day with gradual titration
Tourette’s Disorder: 5–20 mg/day based on weight and response
Dosage adjustment is required with CYP2D6 and CYP3A4 inhibitors/inducers.

Contraindications:

Hypersensitivity to aripiprazole
Dementia-related psychosis in elderly
Children under 6 years (based on indication)

Precautions:

Increased risk of suicidal thoughts in adolescents
Increased mortality and stroke risk in elderly with dementia
Metabolic changes: hyperglycemia, weight gain
Cardiovascular issues, orthostatic hypotension
Seizures, temperature dysregulation, dysphagia

Side Effects:

Common: headache, insomnia, nausea, vomiting, anxiety, drowsiness, dizziness, constipation, weight gain.
In children: somnolence, tremor, extrapyramidal disorder, increased appetite.

Pregnancy and Breastfeeding:
Not recommended during pregnancy or lactation. Safety not established.

Storage Conditions:

Store below 30°C. Protect from light and moisture.

Packaging:

Carton box containing 10 tablets of 15 mg and leaflet.